Barclays initiates coverage on U.S. small & mid-cap biotech stocks

Constellation Brands, Aehr Test Systems And 3 Stocks To Watch Heading Into Monday

Stock Market Today: Nasdaq, S&P 500 Futures Rise As Government Enters 2nd Week Of Shutdown—Plug, Lithium Americas, UiPath In Focus

Oruka Therapeutics Files For Mixed Shelf Of Upto $500 Million - SEC Filing

Pharmacovigilance Scientist

Oruka Therapeutics is developing novel biologics for chronic skin diseases, aiming to provide patients with significant freedom from their conditions. The Pharmacovigilance Scientist plays a critical role in managing drug safety data, collaborating with cross-functional teams to ensure patient safety and regulatory compliance.

Sign up with Google

Sign in with Google